Next Article in Journal
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives
Previous Article in Journal
The Prenatal Microbiome: A New Player for Human Health
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessReview
High-Throughput 2018, 7(4), 39; https://doi.org/10.3390/ht7040039

Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects

1
Departments of Pathology and Pediatric Hematology-Oncology, University of Missouri School of Medicine, Kansas City, MO 64108, USA
2
Children’s Mercy Hospital, Kansas City, MO 64108, USA
*
Author to whom correspondence should be addressed.
Received: 14 November 2018 / Revised: 5 December 2018 / Accepted: 7 December 2018 / Published: 13 December 2018
  |  
PDF [474 KB, uploaded 13 December 2018]
  |  

Abstract

Precision oncologic medicine is an emerging approach for cancer treatment that has recently taken giant steps in solid clinical practice. Recent advances in molecular diagnostics that can analyze the individual tumor’s variability in genes have provided greater understanding and additional strategies to treat cancers. Although tumors can be tested by several molecular methods, the use of next-generation sequencing (NGS) has greatly facilitated our understanding of pediatric cancer and identified additional therapeutic opportunities. Pediatric tumors have a different genetic make-up, with a fewer number of actionable targets than adult tumors. Nevertheless, precision oncology in the pediatric population has greatly improved the survival of patients with leukemia and solid tumors. This review discusses the current status of pediatric precision oncology and the different clinical scenarios in which it can be effectively applied. View Full-Text
Keywords: actionable mutations; next generation sequencing; pediatric cancer; precision medicine actionable mutations; next generation sequencing; pediatric cancer; precision medicine
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Ahmed, A.A.; Vundamati, D.S.; Farooqi, M.S.; Guest, E. Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects. High-Throughput 2018, 7, 39.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
High-Throughput EISSN 2571-5135 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top